The effect of post-discharge educational intervention on patients in achieving objectives in modifiable risk factors six months after discharge following an episode of acute coronary syndrome, (CAM-2 Project): a randomized controlled trial

Table 3 Degree of Achievement of Objectives at Six Months in Both Groups

Objectives (nI/nC)	Intervention (n = 762)	Control (n = 748)	Adjusted^γ Odds ratio	Adjusted OR 95% CI	p-value
Given up smoking (253/200)	76.3	71.0	1.25	0.81-1.94	0.309
BMI ≥ 25 kg/m² (567/547)
< 25 kg/m²	9.9	7.8	1.21	0.79-1.86	0. 373
⇓ BMI ≥ 10%	7.4	6.8	1.15	0.72-1.84	0.564
⇓ BMI ≥ 5%	25.0	19.7	1.31	0.98-1.76	0.068
BMI ≥ 30 kg/m² (212/209)
< 30 kg/m²	25.9	24.9	1.04	0.66-1.63	0.860
⇓ BMI ≥ 10%	11.3	10.5	1.15	0.61-2.17	0.666
⇓ BMI ≥ 5%	32.1	27.8	1.26	0.82-1.93	0.300
Changes in BMI (average) (kg/m²)*	- 0.5	- 0.2	0.35*	0.16-0.55*	< 0.001
Changes in abdominal perimeter (average) (cm)*	- 1.6	- 0.6	1.03*	0.00-2.06*	0.05
Exercise 5 times/week	29.4	23.4	1.29	1.02-1.64	0.033
Exercise 3 times/week	48.4	41.0	1.29	1.05-1.59	0.017
Cholesterol < 175 md/dl	64.7	56.5	1.46	1.17-1.81	0.001
LDL < 100 mg/dl (70 in diabetic patients)	47.9	44.8	1.09	0.87-1.35	0.449
BP < 135/80 mmHg (130/80 in diabetic patients)	46.7	42.4	1.14	0.91-1.41	0.253
Taking of medication (percentage who take it on final visit, out of total given medication on discharge from hospital)
Aspirin (712/698)	97.5	96.0	1.54	0.84-2.83	0.161
Clopidogrel (571/533)	72.9	74.3	0.91	0.69-1.20	0.499
Beta-blockers (621/590)	94.4	94.6	0.93	0.56-1.54	0.769
ACE-inhibitors (400/387)	86.8	84.0	1.31	0.87-1.98	0.192
Angiotensin receptor blocking agent Type II (ARA II) (86/97)	84.9	86.6	0.83	0.35-1.95	0.664
Statins (677/635)	98.1	95.9	0.83	0.35-1.95	0.029

Results in intervention and control columns expressed as % of total number of patients affected by this objective as indicated in the first column, unless otherwise indicated
^γ Differences in means (ANOVA model) or odds ratios [OR, logistic regression] adjusted for age group, education level, history of stroke, medication for cholesterol and tobacco consumption prior to admission, variables with statistical significant differences at baseline in the group of patients included in this analysis. Reference group for all estimates: control group). See interpretation of OR in the results section.
* In these continuous outcome variables, (changes in body mass index [BMI] and abdominal perimeter) the coefficients of the ANOVA model adjusted for the same variables, instead of odds ratios, are presented.
nI/nC: Number of patients in intervention/control groups on which the percentages presented are based when they are not the same as the total indicated in the corresponding column.
CI: Confidence interval

ISSN: 1477-7525